Stock Analiz

NeuroPace Inc (NPCE) stock forecast and price target

Price $7.56 · data as of November 13, 2026

12-month price target

Average target$14.11
Upside / downside+86.7%
Analysts9
ConsensusBuy
Low $7.00Average $14.11High $22.00

Gold marker: average target · white marker: today’s price ($7.56)

Analyst ratings

Strong buy 0Buy 6Hold 4Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.41+38.0%$91M
Next fiscal year
ends December 31, 2027
$-0.32+21.8%$109M
Next quarter
ends December 31, 2026
$-0.14−71.7%$23M
Quarter after
ends March 31, 2027
$-0.10—$25M

Consensus of the analysts covering NeuroPace, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 86.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts NeuroPace’s intrinsic value about 93% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the NeuroPace stock price target?

The average 12-month target from 9 analysts is $14.11, 86.7% above the current price of $7.56 Targets range from $7.00 to $22.00.

Is NeuroPace a buy according to analysts?

The consensus rating is “Buy” (6 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is NeuroPace expected to earn?

Analysts expect EPS of $-0.41 for the fiscal year ending December 31, 2026 and $-0.32 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.